CSMED Share Price Performance
DKK 1.01
-11.78 (-92.08%)
Price DKK 1.01
Share PriceDKK 1.01
CSMED Community Narratives
There are no narratives available yet.
Recent CSMED News & Updates
No updates
CS Medica A/S Key Details
Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
Jan 17, 2025
- Earnings per share (EPS)
- -0.70
- Gross Margin
- 37.92%
- Net Profit Margin
- -114.06%
- Debt/Equity Ratio
- 219.3%
CS Medica A/S Competitors
About CSMED
- Founded
- 2011
- Employees
- 9
- CEO
- WebsiteView website
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name. It also acts as a distributor of other cosmeceuticals and natural cosmetics in the Nordic region. The company was incorporated in 2011 and is based in Copenhagen, Denmark.
Danish Market Performance
- 7 Days: -16.6%
- 3 Months: -12.6%
- 1 Year: -39.1%
- Year to Date: -28.6%
Over the last 7 days, the market has dropped 17%, driven by losses in every sector, especially the Healthcare sector. In the last 12 months the market is down 41%. Looking forward, earnings are forecast to grow by 6.7% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading